Intravenous to Oral (IV:PO) Anti-Infective Conversion Therapy

Cancer Control - United States
doi 10.1177/107327480000700211
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Repurposed Anti-Cancer Drugs: The Future for Anti-Infective Therapy?

Expert Review of Anti-Infective Therapy
VirologyInfectious DiseasesMicrobiology
2020English

The Conversion Ratio From Intravenous Hydromorphone to Oral Opioids in Cancer Patients

Journal of Pain and Symptom Management
NeurologyAnesthesiologyPain MedicineNursing
2017English

Adverse Events Related to Intravenous Antibiotic Therapy: A Prospective Observational Study in the Treatment of Infective Endocarditis

BMJ Open
Medicine
2012English

Anti-Infective Effectiveness of Ascorbic Acid in the Oral Mucosa of Guinea Pigs

2019English

Infective Endocarditis Related to Intravenous Drug User: Report of Four Cases

The Open Infectious Diseases Journal
2018English

Comparison of Intravenous Maxacalcitol Therapy and Oral Calcitriol Pulse Therapy Following Percutaneous Ethanol Injection Therapy (PEIT) for Secondary to Hyperparathyroidism

Nihon Toseki Igakkai Zasshi
2006English

Correction To: Human Organotypic Models for Anti-Infective Research

Current Topics in Microbiology and Immunology
AllergyImmunologyMicrobiology
2019English

Study of Oral Versus Intravenous Iron Therapy in Postpartum Anaemic Women

Journal of Evolution of Medical and Dental Sciences
2017English

Oral and Intravenous Iron Therapy in the Anaemia of Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1950English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy